Cognition Therapeutics, Inc.
CGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27,863 | $55,474 | $60,882 | $140,494 |
| - Cash | $25,009 | $29,922 | $41,562 | $54,721 |
| + Debt | $814 | $1,238 | $1,478 | $0 |
| Enterprise Value | $3,668 | $26,790 | $20,798 | $85,773 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$235 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$33,680 | -$25,509 | -$21,134 | -$10,730 |
| % Margin | – | – | – | – |
| Net Income | -$33,971 | -$25,788 | $757 | -$11,716 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.85 | -0.86 | -0.74 | -0.73 |
| % Growth | 1.2% | -16.2% | -1.4% | – |
| Operating Cash Flow | -$28,474 | -$16,018 | -$18,533 | -$3,631 |
| Capital Expenditures | -$4 | -$147 | -$171 | -$27 |
| Free Cash Flow | -$28,478 | -$16,165 | -$18,704 | -$3,658 |